Eligibility requirements for community pharmacy medication review services in Canada.
作者信息
Pammett Robert, Jorgenson Derek
机构信息
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan.
出版信息
Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006.
Abstract
摘要
相似文献
1
Eligibility requirements for community pharmacy medication review services in Canada.加拿大社区药房药物审查服务的资格要求。
Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006.
2
Descriptive analysis of pharmacy services provided after community pharmacy screening.社区药房筛查后提供的药学服务的描述性分析。
Int J Clin Pharm. 2018 Dec;40(6):1577-1586. doi: 10.1007/s11096-018-0742-5. Epub 2018 Nov 26.
3
Adoption of the Nova Scotia (Canada) Community Pharmacy Medication Management Program, 1-Year Post-Initiation.加拿大新斯科舍省社区药房药物管理项目实施一年后采用情况。
J Popul Ther Clin Pharmacol. 2017 Feb 1;24(1):e46-e55. doi: 10.22374/17106222.24.1.6.
4
Medication Therapy Management in community pharmacy practice: core elements of an MTM service (version 1.0).社区药房实践中的药物治疗管理：药物治疗管理服务的核心要素（第1.0版）
J Am Pharm Assoc (2003). 2005 Sep-Oct;45(5):573-9. doi: 10.1331/1544345055001256.
5
Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study.社区药房药物审查与出院后死亡和再入院：倾向评分匹配队列研究。
BMJ Qual Saf. 2020 Jan;29(1):41-51. doi: 10.1136/bmjqs-2019-009545. Epub 2019 Aug 8.
6
Expanding the clinical role of community pharmacy: A qualitative ethnographic study of medication reviews in Ontario, Canada.拓展社区药房的临床作用：加拿大安大略省药物审查的定性民族志研究。
Health Policy. 2018 Mar;122(3):256-262. doi: 10.1016/j.healthpol.2017.10.007. Epub 2017 Nov 4.
7
Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.在威斯康星州建立新型供应商和支付方合作伙伴关系，以补偿药剂师提供以质量为导向的药房和药物治疗管理服务。
J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):642-51. doi: 10.1331/JAPhA.2009.08158.
8
Medication review service implementation in community pharmacy settings: Scoping review with focus on implementation studies.社区药房中药物审查服务的实施：以实施研究为重点的范围综述。
Res Social Adm Pharm. 2020 Jul;16(7):875-885. doi: 10.1016/j.sapharm.2019.10.005. Epub 2019 Oct 7.
9
Community pharmacy incident reporting: a new tool for community pharmacies in Canada.社区药房事件报告：加拿大社区药房的一种新工具。
Healthc Q. 2010;13 Spec No:16-24. doi: 10.12927/hcq.2010.21961.
10
A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.一项针对专业间药房沟通伙伴关系 (PROMPT) 的发展评估，以改善从医院到社区的护理过渡：一项混合方法研究。
BMC Health Serv Res. 2020 Feb 10;20(1):99. doi: 10.1186/s12913-020-4909-0.
引用本文的文献
1
The Ontario Pharmacy Evidence Network Atlas of MedsCheck services.安大略省药房药物检查服务证据网络地图集。
Can Pharm J (Ott). 2022 Mar 9;155(3):151-156. doi: 10.1177/17151635221080457. eCollection 2022 May-Jun.
2
The Saskatchewan Medication Assessment Program for Patients With Renal Failure: A Qualitative Study to Understand Health Care Provider Perspectives.萨斯喀彻温省肾衰竭患者药物评估项目：一项了解医疗服务提供者观点的定性研究。
Can J Kidney Health Dis. 2020 Oct 22;7:2054358120954028. doi: 10.1177/2054358120954028. eCollection 2020.
3
Community pharmacists' evolving role in Canadian primary health care: a vision of harmonization in a patchwork system.社区药剂师在加拿大初级卫生保健中不断演变的角色：拼凑系统中的协调愿景。
Pharm Pract (Granada). 2020 Oct-Dec;18(4):2171. doi: 10.18549/PharmPract.2020.4.2171. Epub 2020 Oct 18.
4
Impact of pharmacist-led medication assessments on opioid utilization.药剂师主导的药物评估对阿片类药物使用的影响。
Can Pharm J (Ott). 2020 Mar 13;153(3):148-152. doi: 10.1177/1715163520908285. eCollection 2020 May-Jun.
5
Community pharmacists' experiences with the Saskatchewan Medication Assessment Program.社区药剂师参与萨斯喀彻温省药物评估项目的经历。
Can Pharm J (Ott). 2019 Feb 27;152(3):193-203. doi: 10.1177/1715163519827980. eCollection 2019 May-Jun.
6
Current perspectives on pharmacist home visits: do we keep reinventing the wheel?药剂师家访的当前观点：我们是否在不断地 reinventing the wheel（此处可意译为“做重复劳动”或“白费力气”）？
Integr Pharm Res Pract. 2018 Oct 1;7:141-159. doi: 10.2147/IPRP.S148266. eCollection 2018.
7
Shared decision making and experiences of patients with long-term conditions: has anything changed?慢性病患者的共同决策与经历：有什么变化吗？
BMC Health Serv Res. 2018 Oct 10;18(1):763. doi: 10.1186/s12913-018-3575-y.
8
Uptake of the Medication Assessment Program in Saskatchewan: Tracking claims during the first year.萨斯喀彻温省药物评估项目的实施情况：第一年的理赔跟踪
Can Pharm J (Ott). 2017 Nov 29;151(1):24-28. doi: 10.1177/1715163517744228. eCollection 2018 Jan-Feb.
9
Exploring the practical application of the concept of frailty in pharmacy practice.探索衰弱概念在药学实践中的实际应用。
Can Pharm J (Ott). 2017 Nov 20;151(1):13-16. doi: 10.1177/1715163517744229. eCollection 2018 Jan-Feb.
10
Pharmaceutical care in Brazil's primary health care.巴西初级卫生保健中的药学服务。
Rev Saude Publica. 2017 Nov 13;51(suppl 2):6s. doi: 10.11606/S1518-8787.2017051007109.
本文引用的文献
1
A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.一项关于药剂师主导的按服务收费药物审查的系统评价和荟萃分析。
Br J Clin Pharmacol. 2014 Jan;77(1):102-15. doi: 10.1111/bcp.12140.
2
Risk factors for adverse drug events among older adults in the ambulatory setting.门诊环境中老年人药物不良事件的风险因素。
J Am Geriatr Soc. 2004 Aug;52(8):1349-54. doi: 10.1111/j.1532-5415.2004.52367.x.
3
Adverse drug events in high risk older outpatients.高危老年门诊患者的药物不良事件
J Am Geriatr Soc. 1997 Aug;45(8):945-8. doi: 10.1111/j.1532-5415.1997.tb02964.x.
4
Indicators for the selection of ambulatory patients who warrant pharmacist monitoring.需要药剂师监测的门诊患者的选择指标。
Am J Hosp Pharm. 1989 Apr;46(4):729-32.
Zotero 插件